The iron homeostasis network and hepatitis C virus – a new challenge in the era of directly acting antivirals

References

• Dubuisson J, Cosset FL. Virology and cell biology of the hepatitis C virus life cycle: an update. J Hepatol. 2014; 61(1 Suppl):S3-S13; PMID:25443344; http://dx.doi.org/10.1016/j.jhep.2014.06.031
   PubMed Web of Science ®Google Scholar
• Thomas DL. Global control of hepatitis C: where challenge meets opportunity. Nat Med 2013; 19:850-8; PMID:23836235; http://dx.doi.org/10.1038/nm.3184
   PubMed Web of Science ®Google Scholar
• GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385:117-71; PMID:25530442; http://dx.doi.org/10.1016/S0140-6736(14)61682-2
   PubMed Web of Science ®Google Scholar
• Cacoub P, Gragnani L, Comarmond C, Zignego AL. Extrahepatic manifestations of chronic hepatitis C virus infection. Dig Liver Dis 2014; 46 Suppl 5:S165-73; PMID:25458776; http://dx.doi.org/10.1016/j.dld.2014.10.005
   PubMedGoogle Scholar
• Götte M, Feld JJ. Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights. Nat Rev Gastroenterol Hepatol 2016; 13(6):338-51; PMID:27147491; http://dx.doi.org/10.1038/nrgastro.2016.60.
   PubMed Web of Science ®Google Scholar
• Kim AY, Onofrey S, Church DR. An epidemiologic update on hepatitis C infection in persons living with or at risk of HIV infection. J Infect Dis 2013; 207 Suppl 1:S1-6; PMID:24136791; http://dx.doi.org/10.1093/infdis/jis927
   PubMed Web of Science ®Google Scholar
• Verma R, Khanna P, Chawla S. Hepatitis C vaccine. Need of the hour. Hum Vaccin Immunother 2014; 10:1927-9; PMID:25424801; http://dx.doi.org/10.4161/hv.29033
   PubMed Web of Science ®Google Scholar
• Heim MH. Innate immunity and HCV. J Hepatol 2013; 58:564-74; PMID:23063572; http://dx.doi.org/10.1016/j.jhep.2012.10.005
   PubMedGoogle Scholar
• Foka P, Dimitriadis A, Karamichali E, Kyratzopoulou E, Giannimaras D, Koskinas J, Varaklioti A, Mamalaki A, Georgopoulou U. Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency. Virulence 2016 Apr 8:1-12. [Epub ahead of print]
   PubMedGoogle Scholar
• Theurl I, Zoller H, Obrist P, Datz C, Bachmann F, Elliott RM, Weiss G. Iron regulates hepatitis C virus translation via stimulation of expression of translation initiation factor 3. J Infect Dis 2004; 190:819-25; PMID:15272411
   PubMed Web of Science ®Google Scholar
• Fillebeen C, Pantopoulos K. Iron inhibits replication of infectious hepatitis C virus in permissive Huh7.5.1 cells. J Hepatol 2010; 53:995-9; PMID:20813419; http://dx.doi.org/10.1016/j.jhep.2010.04.044
   PubMed Web of Science ®Google Scholar
• Shan Y, Lambrecht RW, Bonkovsky HL. Association of hepatitis C virus infection with serum iron status: analysis of data from the third National Health and Nutrition Examination Survey. Clin Infect Dis 2005; 40:834-41; PMID:15736017
   PubMed Web of Science ®Google Scholar
• Fujita N, Sugimoto R, Urawa N, Araki J, Mifuji R, Yamamoto M, Horiike S, Tanaka H, Iwasa M, Kobayashi Y, et al. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. J Gastroenterol Hepatol 2007; 22:1886-93; PMID:17914965
   PubMed Web of Science ®Google Scholar
• Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased deacetylase activity. Hepatology 2008; 48:1420-29; PMID:18671304; http://dx.doi.org/10.1002/hep.22486
   PubMed Web of Science ®Google Scholar
• Nishina S, Hino K, Korenaga M, Vecchi C, Pietrangelo A, Mizukami Y, Furutani T, Sakai A, Okuda M, Hidaka I, et al. Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. Gastroenterology 2008; 134:226-38; PMID:18166355; http://dx.doi.org/10.1053/j.gastro.2007.10.011
   PubMed Web of Science ®Google Scholar
• Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta 2012; 1823:1434-43; PMID:22306005; http://dx.doi.org/10.1016/j.bbamcr.2012.01.014
   PubMed Web of Science ®Google Scholar
• Aoki CA, Rossaro L, Ramsamooj R, Brandhagen D, Bowlus CL. Liver hepcidin correlates with iron stores, but not inflammation, in patients with chronic hepatitis C. J Clin Gastroenterol 2005; 39:71-4; PMID:15599216
   PubMed Web of Science ®Google Scholar
• Fujita N, Sugimoto R, Motonishi S, Tomosugi N, Tanaka H, Takeo M, Iwasa M, Kobayashi Y, Hayashi H, Kaito M, et al. Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. J Hepatol 2008; 49:702-10; PMID:18620776; http://dx.doi.org/10.1016/j.jhep.2008.05.014
   PubMed Web of Science ®Google Scholar
• Sikorska K, Romanowski T, Stalke P, Izycka Swieszewska E, Bielawski KP. Association of hepcidin mRNA expression with hepatocyte iron accumulation and effects of antiviral therapy in chronic hepatitis C infection. Hepat Mon 2014; 14:e21184; http://dx.doi.org/10.5812/hepatmon.21184. eCollection 2014 Nov; PMID:25598789
   PubMedGoogle Scholar
• Girelli D, Pasino M, Goodnough JB, Nemeth E, Guido M, Castagna A, Busti F, Campostrini N, Martinelli N, Vantini I, et al. Reduced serum hepcidin levels in patients with chronic hepatitis C. J Hepatol 2009; 51:845-52; PMID:19729219; http://dx.doi.org/10.1016/j.jhep.2009.06.027
   PubMed Web of Science ®Google Scholar
• Tai AW, Benita Y, Peng LF, Kim SS, Sakamoto N, Xavier RJ, Chung RT. A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. Cell Host Microbe 2009; 3:298-307; PMID:19286138; http://dx.doi.org/10.1016/j.chom.2009.02.001
   PubMed Web of Science ®Google Scholar
• Bartolomei G, Cevik RE, Marcello A. Modulation of hepatitis C virus replication by iron and hepcidin in Huh7 hepatocytes. J Gen Virol 2011; 92:2072-81; PMID:21593278; http://dx.doi.org/10.1099/vir.0.032706-0
   PubMed Web of Science ®Google Scholar
• Liu H, Trinh TL, Dong H, Keith R, Nelson D, Liu C. Iron regulator hepcidin exhibits antiviral activity against hepatitis C virus. Plos One 2012; 10:e46631; PMID:23110054; http://dx.doi.org/10.1371/journal.pone.0046631
   PubMedGoogle Scholar
• Wróblewska A, Bernat A, Woziwodzka A, Markiewicz J, Romanowski T, Bielawski KP, Smiatacz T, Sikorska K. Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C. Clin Exp Med 2016 Apr 28. [Epub ahead of print]; PMID:27125837
   PubMedGoogle Scholar